Table 2.
Incidence of Schneiderian membrane perforation, postoperative measurements, implant placement, and complications. Pat = Patients. Imp = Implants. PSM = Perforation of Schneiderian Membrane. NE = Not Specified. ATB = Antibiotic. NSAIDs = Non-steroidal analgesics. CLH = Chlorhexidine.
| Author, Year | N.° Pat. | N.° sinus | N.° Imp | N.° PSM | Perforation Incidence (%) |
Postoperative Care | Implant Placement | Postoperative Complications | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Shlomi et al., 2004 [10] | 63 | 73 | 253 | 20 | 28% | NE | Simultaneous | NE | ||
| 2 phases 4–6 months | ||||||||||
| Hernández-Alfaro et al., 2007 [18] | 338 | 474 | 1166 | 104 | 21.9% | ATB/7 days NSAID |
Simultaneous | NE | ||
| Oh and Kraut 2011 [21] | 128 | 175 | 438 | 60 | 34% | NE | Simultaneous | 4 sinusitis | ||
| 2 phases 8 months | ||||||||||
| Gehrke et al., 2012 [26] | 10 | 10 | 18 | 10 | NE | ATB/7 days NSAID |
2 phases 6 months |
No complications | ||
| Cha et al., 2012 [28] | 161 | 217 | 462 | 35 | 16.1% | ATB/5 days NSAID/5 days Corticosteroids CLH 0.2% |
Simultaneous | NE | ||
| Froum et al., 2013 [22] | 23 | 40 | 80 | 15 | 37% | ATB/7–10 days CLH 0.12% |
2 phases 6–9 months |
NE | ||
| Kim et al., 2016 [27] | 41 | 41 | 99 | 41 | NE | ATB/3 days | Simultaneous | 8 sinusitis | ||
| 2 phases 4–6 months |
6 local infections | |||||||||
| 10 rhinorrheas | ||||||||||
| Öncü and Kaymaz. 2017 [24] | 16 | 20 | 35 | 10 | NE | ATB/14 days NSAID/14 days CLH 0.12% |
2 phases 6–8 months |
NE | ||
| de Almeida-Ferreira et al., 2017 [23] | 531 | 745 | 1588 | 237 | 31.8% | ATB/10 days NSAID CLH 0.12% |
Simultaneous | NE | ||
| 2 phases 6–10 months | ||||||||||
| Krennmair et al., 2022 [25] | 355 | 434 | 913 | 103 | 23.80% | NSAID, CLH, ATB/8 days, decongestant spray | Simultaneous | Sinusitis | ||
| 10 | 4 | |||||||||
| 2 phases | NE | Graft necrosis | ||||||||
| 7 | 1 | |||||||||
| Total | 1666 | 2229 | 5052 | 635 | ||||||
| Media | 29.42% | |||||||||